Literature DB >> 16673680

Are we measuring what matters in health technology assessment of disease management? Systematic literature review.

Lotte Steuten1, Bert Vrijhoef, Hans Severens, Frits van Merode, Cor Spreeuwenberg.   

Abstract

OBJECTIVES: An overview was produced of indicators currently used to assess disease management programs and, based on these findings, provide a framework regarding sets of indicators that should be used when taking the aims and types of disease management programs into account.
METHODS: A systematic literature review was performed.
RESULTS: Thirty-six studies met the inclusion criteria. It appeared that a link between aims of disease management and evaluated structure, process, as well as outcome indicators does not exist in a substantial part of published studies on disease management of diabetes and asthma/chronic obstructive pulmonary disease, especially when efficiency of care is concerned. Furthermore, structure indicators are largely missing from the evaluations, although these are of major importance for the interpretation of outcomes for purposes of decision-making. Efficiency of disease management is mainly evaluated by means of process indicators; the use of outcome indicators is less common. Within a framework, structure, process, and outcome indicators for effectiveness and efficiency are recommended for each type of disease management program.
CONCLUSIONS: The link between aims of disease management and evaluated structure, process, and outcome indicators does not exist in a substantial part of published studies on disease management. The added value of this study mainly lies in the development of a framework to guide the choice of indicators for health technology assessment of disease management.

Entities:  

Mesh:

Year:  2006        PMID: 16673680     DOI: 10.1017/s0266462306050835

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  6 in total

1.  Effect of an interactive voice response system on oral anticoagulant management.

Authors:  Natalie Oake; Carl van Walraven; Marc A Rodger; Alan J Forster
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

2.  Performing Economic Evaluation of Integrated Care: Highway to Hell or Stairway to Heaven?

Authors:  Apostolos Tsiachristas; K Viktoria Stein; Silvia Evers; Maureen Rutten-van Mölken
Journal:  Int J Integr Care       Date:  2016-10-19       Impact factor: 5.120

3.  Using the Dynamic SWOT Analysis to Assess Options for Implementing the HB-HTA Model.

Authors:  Barbara Więckowska; Monika Raulinajtys-Grzybek; Katarzyna Byszek
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

4.  Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project.

Authors:  Liesbeth Borgermans; Geert Goderis; Carine Van Den Broeke; Geert Verbeke; An Carbonez; Anna Ivanova; Chantal Mathieu; Bert Aertgeerts; Jan Heyrman; Richard Grol
Journal:  BMC Health Serv Res       Date:  2009-10-07       Impact factor: 2.655

5.  Diversity in diabetes care programmes and views on high quality diabetes care: are we in need of a standardized framework?

Authors:  Liesbeth A D Borgermans; Geert Goderis; Marielle Ouwens; Johan Wens; Jan Heyrman; Richard P T M Grol
Journal:  Int J Integr Care       Date:  2008-04-24       Impact factor: 5.120

6.  Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial.

Authors:  Melinde R S Boland; Annemarije L Kruis; Apostolos Tsiachristas; Willem J J Assendelft; Jacobijn Gussekloo; Coert M G Blom; Niels H Chavannes; Maureen P M H Rutten-van Mölken
Journal:  BMJ Open       Date:  2015-11-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.